阿戈梅拉丁:神经发育障碍的潜在多目标化合物
Rosa Savino1, Anna Nunzia Polito1, Gabriella Marsala2
1Department of Woman and Child, Neuropsychiatry for Child and Adolescent Unit, General Hospital "Riuniti" of Foggia, 71122 Foggia, Italy.
阿戈梅拉丁 (AGM) 是一种新型抗抑郁药,显示出治疗神经发育障碍的潜力,如ADHD和ASD. 它对昼夜节律和神经递质的独特作用可能会改善儿童和青少年的认知和神经元可塑性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 发育障碍 发育障碍 发展障碍
背景情况:
- 阿戈梅拉丁 (AGM) 是一种非典型的抗抑郁药.
- 它的作用是作为黑激素受体激动剂和黑激素受体对抗剂.
- 目前使用仅限于成人抑郁症,因为儿科数据稀缺.
研究的目的:
- 审查Agomelatine在神经发育障碍中的潜力.
- 探索AGM在ADHD和ASD等疾病中的作用.
- 评估它对儿科患者群体的适用性.
主要方法:
- 对Agomelatine现有研究和病例报告的审查.
- 对AGM药理机制的分析.
- 评估其对神经传递和神经元可塑性的影响.
主要成果:
- AGM可能会增强细胞骨相关蛋白 (ARC) 表达,改善学习和记忆.
- 它调节了谷氨酸作用的神经传递,影响了情绪和认知.
- AGM充当抗抑郁药,精神刺激剂,并促进神经元的可塑性.
结论:
- 阿戈梅拉丁显示出治疗自闭症谱系障碍 (ASD) 和注意力缺陷和多动症障碍 (ADHD) 的潜力.
- 它重新同步昼夜节律和改善认知功能的能力是有希望的.
- 良好的耐受性表明青少年和儿科使用的潜力.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: Glutamate Antagonists
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drugs Affecting Neurotransmitter Synthesis
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
